Marinus Pharmaceuticals Operating Expenses 2011-2026 | MRNS

Annual Operating Expenses Marinus Pharmaceuticals

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	69.7 M	54.4 M	37.2 M	19 M	28.2 M	24.4 M	11.9 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
69.7 M	11.9 M	35 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	216 M	$ 21.66	1.14 %	$ 1.01 B	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.7 M	$ 0.9	-0.2 %	$ 6.62 M	China
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	708 M	$ 22.33	1.66 %	$ 3.7 B	USA
Esperion Therapeutics ESPR	343 M	$ 1.94	1.31 %	$ 403 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Galectin Therapeutics GALT	20.1 M	$ 2.38	2.33 %	$ 152 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Greenwich LifeSciences GLSI	16 M	$ 24.07	-0.58 %	$ 313 M	USA
Heron Therapeutics HRTX	281 M	$ 1.18	-0.84 %	$ 197 M	USA
ImmuCell Corporation ICCC	9.8 M	$ 8.26	-1.07 %	$ 74.6 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
InflaRx N.V. IFRX	52.4 M	$ 1.61	8.78 %	$ 152 M	Germany
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Innate Pharma S.A. IPHA	63 M	$ 1.39	0.72 %	$ 235 M	France
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Inventiva S.A. IVA	36.2 M	$ 5.11	-0.78 %	$ 138 M	France
Jaguar Health JAGX	36 M	$ 0.29	-25.25 %	$ 676 K	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
KalVista Pharmaceuticals KALV	161 M	$ 19.09	-2.75 %	$ 1.03 B	Britain
BioNTech SE BNTX	512 M	$ 102.36	-2.94 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	4.49 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	85.5 M	$ 4.11	0.61 %	$ 439 M	USA
Arcutis Biotherapeutics ARQT	137 M	$ 23.18	-0.34 %	$ 2.95 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	145 M	$ 1.43	-0.7 %	$ 381 M	Britain
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
Ligand Pharmaceuticals Incorporated LGND	115 M	$ 240.72	4.09 %	$ 4.4 B	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Eli Lilly and Company LLY	11.8 B	$ 874.81	-1.06 %	$ 785 B	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 2.9	-0.34 %	$ 4.77 M	Israel
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA